Life Science REIT Balance Sheet Health

Financial Health criteria checks 2/6

Life Science REIT has a total shareholder equity of £267.2M and total debt of £118.1M, which brings its debt-to-equity ratio to 44.2%. Its total assets and total liabilities are £402.4M and £135.1M respectively. Life Science REIT's EBIT is £9.4M making its interest coverage ratio 1.5. It has cash and short-term investments of £13.5M.

Key information

44.2%

Debt to equity ratio

UK£118.07m

Debt

Interest coverage ratio1.5x
CashUK£13.53m
EquityUK£267.23m
Total liabilitiesUK£135.13m
Total assetsUK£402.36m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: JL6's short term assets (£16.2M) exceed its short term liabilities (£13.5M).

Long Term Liabilities: JL6's short term assets (£16.2M) do not cover its long term liabilities (£121.6M).


Debt to Equity History and Analysis

Debt Level: JL6's net debt to equity ratio (39.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if JL6's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: JL6 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if JL6 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies